Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
COLUMBUS: Encorafenib plus binimetinib versus vemurafenib or encorafenib in...
Prof Dirk Schadendorf - Uniklinik Essen, Essen, Germany
COLUMBUS: Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma ( Prof Dirk Schadendorf - Uniklinik Essen, Essen, Germany )
29 Oct 2018
Modern melanoma treatment in the UK
Dr Joseph Sacco - University of Liverpool, Liverpool, UK
Modern melanoma treatment in the UK ( Dr Joseph Sacco - University of Liverpool, Liverpool, UK )
26 Oct 2018
Current clinical landscape for ALK non-small cell lung cancer patients
Dr Riyaz Shah and Dr Maurice Perol
Current clinical landscape for ALK non-small cell lung cancer patients ( Dr Riyaz Shah and Dr Maurice Perol )
26 Oct 2018
Latest advances in treatment for ALK positive NSCLC
Prof Gordon McVie, Dr Lázaro Quintela
Latest advances in treatment for ALK positive NSCLC ( Prof Gordon McVie, Dr Lázaro Quintela )
26 Oct 2018
The case for biosimilars
Dr Hans-Christian Kolberg - Marienhospital, Bottrop, Germany
The case for biosimilars ( Dr Hans-Christian Kolberg - Marienhospital, Bottrop, Germany )
26 Oct 2018
Highlights in early non-metastatic NSCLC and thoracic tumours
Dr Enriqueta Felip - Vall d'Hebron University Hospital (VHIO), Barcelona, Spain
Highlights in early non-metastatic NSCLC and thoracic tumours ( Dr Enriqueta Felip - Vall d'Hebron University Hospital (VHIO), Barcelona, Spain )
26 Oct 2018
Anti–PD-L1 atezolizumab or chemotherapy as second-line therapy in patients with...
Prof Jean-Louis Pujol - CHRU de Montpellier, Hôpital Arnaud de Villeneuve...
Anti–PD-L1 atezolizumab or chemotherapy as second-line therapy in patients with SCLC ( Prof Jean-Louis Pujol - CHRU de Montpellier, Hôpital Arnaud de Villeneuve, Montpellier, France )
26 Oct 2018
Combination strategies of immunotherapy in breast cancer
Prof Guiseppe Curigliano - European Institute of Oncology, Milan, Italy
Combination strategies of immunotherapy in breast cancer ( Prof Guiseppe Curigliano - European Institute of Oncology, Milan, Italy )
26 Oct 2018
Highlights in SCLC from ESMO 2018
Dr Noemi Reguart - University of Barcelona, Barcelona, Spain
Highlights in SCLC from ESMO 2018 ( Dr Noemi Reguart - University of Barcelona, Barcelona, Spain )
26 Oct 2018
ABOUND.sqm: nab-paclitaxel and carboplatin induction followed by nab-paclitaxel...
Dr David R. Spigel - Tennessee Oncology, Nashville, USA
ABOUND.sqm: nab-paclitaxel and carboplatin induction followed by nab-paclitaxel maintenance in NSCLC ( Dr David R. Spigel - Tennessee Oncology, Nashville, USA )
26 Oct 2018
Safety analysis of entrectinib for NTRK fusion tumours
Dr George D. Demetri - Harvard Cancer Center, Boston, USA
Safety analysis of entrectinib for NTRK fusion tumours ( Dr George D. Demetri - Harvard Cancer Center, Boston, USA )
26 Oct 2018
TRITON2: Evaluation of rucaparib in patients with metastatic castration...
Dr Josep Piulats - IDIBELL, Barcelona, Spain
TRITON2: Evaluation of rucaparib in patients with metastatic castration-resistant prostate cancer ( Dr Josep Piulats - IDIBELL, Barcelona, Spain )
26 Oct 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation